Oral fish oil evidence does not settle intravenous heart-rhythm safety
A review found an atrial fibrillation risk signal with long-term oral treatment, while its reassurance about short-term intravenous use relied on theoretical reasoning.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The reviewed meta-analyses consistently linked long-term oral fish oil treatment to more atrial fibrillation, although the authors identified possible biases and conflicting recurrence-trial results. Their assessment of intravenous fish oil was theoretical. It suggests a different exposure pattern may matter, but does not directly demonstrate heart-rhythm safety in critically ill patients.
The intravenous conclusion rests on theoretical estimates of fatty acid concentrations and heart tissue content. The abstract reports no direct intravenous trial result for atrial fibrillation, and oral studies varied in how they identified it.
A question about transferring evidence
The question was whether a risk observed with long-term oral treatment could be extended to short-term intravenous nutrition. The authors considered treatment duration, patient group and predicted fatty acid exposure when examining that transfer.
Occurrence and recurrence are different outcomes
The oral evidence also differed by outcome: meta-analyses addressed atrial fibrillation occurrence, while other trials studied recurrence in people already affected. Those are distinct clinical questions, which limits how simply their results can be combined.
The original publication
Does parenteral Omega-3 fatty acid administration increase the risk of atrial fibrillation? An analysis of the current evidence.
Hartl WH, Meybohm P, Pirlich M et al.
Clin Nutr · 2025
- PubMed ID
- 41314109
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.